Collegium Pharmaceutical, Inc. (COLL) Stock Overview
Explore Collegium Pharmaceutical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Collegium Pharmaceutical, Inc. (COLL)
Key Financials
Key Financials
Market Cap
721M
P/E Ratio
14.75
EPS (TTM)
$7.97
ROE
0.16%
COLL Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Collegium Pharmaceutical, Inc. (NASDAQ: COLL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Collegium Pharmaceutical, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of COLL on the NASDAQ shows an RSI of 29.68, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $41.99 for the NASDAQ listing.
Key metrics behind Collegium Pharmaceutical, Inc.'s NASDAQ-traded stock include a P/E ratio of 14.75 and a market capitalization of 721M. Combined with our AI analysis, these give both institutional and retail investors a clear view of COLL on the NASDAQ.